References
- Wines BD, Gavin A, Powell MS, Steinitz M, Buchanan RRC, Hogarth PM. Soluble FcγRIIa inhibits rheumatoid factor binding to immune complexes. Immunology 2003; 109: 246–254
- Masuda M, Morimoto T, de Haas M, Nishimura N, Nakamoto K, Okuda K, Komiyama Y, Ogawa R, Takahashi H. Increase of soluble FcγRIIIa derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritis. J Rheumatol 2003; 30: 1904–1906
- Moldovan I, Gallon J, Maridonneau-Parini I, Roman S, Mathiot C, Fridman WH, Sautes-Fridman C. Regulation of production of soluble Fc gamma receptor type III in normal and pathological conditions. Immunol Lett 1999; 68: 125–134
- Szucs G, Kavai M, Csipo I, Szegedi Gy. Correlation of IgG Fc receptors on granulocytes with serum immune complex level in systemic lupus erythematosus. Scand J Immunol 1995; 42: 577–580
- Seres T, Csipo I, Kiss E, Szegedi Gy, Kavai M. Correletion of Fcγ receptor expression of monocytes with clearance function by macrophages in systemic lupus erythematosus. Scand J Immunol 1998; 48: 307–311
- Hellmich B, Csernok E, de Haas M, von dem Borne AEG, Schatz H, Gross WL, Schnabel A. Low Fcγ receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty's syndrome or systemic lupus erythematosus. Am J Med 2002; 113: 134–139
- Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725
- Astier A, de la Salle H, Moncuit J, Freund M, Cazenave JP, Fridman WH, Hanau D, Teillaud J-L. Detection and quantification of secreted soluble FcγRIIA in human sera by an enzyme-linked immunosorbent assay. J Immunol Methods 1993; 166: 1–10
- Medgyesi D, Uray K, Sallai K, Hudecz F, Koncz G, Abramson J, Pecht I, Sarmay G, Gergely J. Functional mapping of the Fc gamma RII binding site on human IgG1 by synthetic peptides. Eur J Immunol 2004; 34: 1127–1135
- Huizinga TWJ, Ioan-Facsinay A. Soluble FcγRIIIa as a marker for rheumatoid arthritis: The use of genetics in selected populations to study pathogenetic pathway. J Rheumatol 2003; 30: 1904–1906
- Hutin P, Lamour A, Pennec YL, Soubrane C, Dien G, Khayat D, Youinou P. Cell-free Fc-gamma receptor III in sera from patients with systemic lupus eryrhematosus: Correlation with clinical and biological features. Int Arch Allergy Immunol 1994; 103: 23–27
- Preynat-Seauve O, Villiers CL, Jourdan G, Richard MJ, Plumas J, Favier A, March PN, Favrot MC. An interaction between CD16 and CR3 enhances iC3b binding to CR3 is lost during differentiation of monocytes into dendritic cells. Eur J Immunol 2004; 34: 147–155